Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. - Wikidata - wikimedia - TriplyDB

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

http://www.wikidata.org/entity/Q53300055

about

Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus Advancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% cure Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation Histomorphometry of brain tumours.Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence.Recent advances in embryonal tumours of the central nervous system.Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2 Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.Pediatric neuro-oncology: current status and future directions.Medulloblastoma: recurrence and metastasis.Medulloblastoma-translating discoveries from the bench to the bedside.The new WHO 2016 classification of brain tumors-what neurosurgeons need to know.Pleiotropic role for MYCN in medulloblastoma.A mouse model of the most aggressive subgroup of human medulloblastoma Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.Neuronal differentiation associated with Gli3 expression predicts favorable outcome for patients with medulloblastoma.Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior.Accumulation of genomic aberrations during clinical progression of medulloblastoma.Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.Stratification of medulloblastoma on the basis of histopathological grading.Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.Histologic features and prognosis in pediatric medulloblastoma.Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.

P2860

Q24801678-32A9BAE0-1A05-4C47-8AAA-F8049A9CDF15 Q27027799-3A052D01-5532-41A2-80E0-C49251A3A697 Q28288622-7D615DD0-1831-4F5C-AE1B-71F5FFCF7E11 Q28299667-5087F44E-B82C-47BE-B837-B3C007EB0A86 Q34895825-A1A92564-9B48-47C8-84BE-CD8CC7F65CAC Q35860899-0B56DA99-6F54-4BFE-85FA-9E4A58E2811F Q36007971-AAA6498C-3E55-4C83-9DB5-993415066032 Q36025403-CFDDB604-E2DC-4C67-80E2-CCD7EFABCD72 Q36476670-7241DE74-65F6-41EF-9CB3-C0F5964A7C78 Q36610866-A79291A4-AAA1-4366-84F7-7659C3172DCC Q36616158-2BA7FAE4-721C-43A9-A569-BC202B5A6F30 Q36629427-F579DF5B-788C-484C-849A-7F122C6E6052 Q37119630-59BCFB6D-1E48-4674-9B9F-D6C567B40DC2 Q37284365-5759E5FE-888C-48B9-BA5A-80B842DD3854 Q37736255-2891A2CC-738B-4E50-A08B-CE9B9A3AAA84 Q38035070-2C2C9F78-935C-459D-AFD9-2036C45FB6B5 Q38233118-53AF8D0D-4A2B-464E-96E8-862B016E1DC8 Q38263111-3B942502-E896-46EE-B5E9-ABF92D15E47F Q39091307-BECC7CAF-038D-49C2-ADC5-CF2A7741DBDD Q40461175-B0A5052C-A11C-43CB-9B21-E8BAA881EA3F Q41484437-AAEB5BF2-C930-4811-BEC5-7BA39D29B686 Q42739353-0D3CFB78-3545-4524-A53D-F8FDF6E839DF Q43631246-23F4A2AB-1BF1-4624-8584-B06639D1E0F7 Q46848199-3C878276-2751-4557-BF38-FAFEB6C96236 Q47340801-EEBCBEEC-89A4-41A3-8D22-EAA54F010368 Q47363064-DDA7FBB1-CEA6-4444-8AB0-753870EA2238 Q47376346-2FF40436-594F-45F9-A0C5-F52C8A80BE7C Q48227672-78D370F9-3844-4382-AD2E-383F181F5604 Q48966907-93DAD968-205A-4982-B262-B90659B55EAB Q51771306-C9275796-3D26-495C-BC27-80071BBA1933 Q53255752-C0D42130-F60E-4E22-8F4A-F5142217CC75 Q54709976-5D908A24-7792-4433-BC10-9C02002E9995 Q55462103-7099DE10-9C5B-413B-B547-4519F1C8C7C1 Q55463984-63C43F38-3413-49CA-9CFB-BDCE138DDD71 Q55467240-BD6F586B-2A29-47FF-9AC5-292E29857A9B Q55470152-EBFAB201-EB63-460E-86C5-B86968E44570

P2860

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

http://www.wikidata.org/entity/Q53300055

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Morphophenotypic variation pre ...... desmoplastic medulloblastomas.

@en

Morphophenotypic variation pre ...... desmoplastic medulloblastomas.

@nl

type

label

Morphophenotypic variation pre ...... desmoplastic medulloblastomas.

@en

Morphophenotypic variation pre ...... desmoplastic medulloblastomas.

@nl

prefLabel

Morphophenotypic variation pre ...... desmoplastic medulloblastomas.

@en

Morphophenotypic variation pre ...... desmoplastic medulloblastomas.

@nl

P1433

Q53300055-D9B44703-D3F4-433E-B1ED-DDB34082F8CD

P1476

Q53300055-25386746-5D53-41FF-8DD0-B15F6F18EE02

P2093

Q53300055-1AEC562A-B7CB-46B1-9E6A-B7FD1197DDF9

Q53300055-24B5D98A-570B-4260-9E27-481A9ED95353

Q53300055-2E996DA5-1968-4FB3-A5F4-88C2825C80E8

Q53300055-81DFE2AB-6900-45E3-B82C-A952E0F07DA0

Q53300055-A0F4DBF5-2624-4514-982E-998C2ECB4E4B

Q53300055-B0D9D42C-4983-4729-9A58-898B1BE6135E

Q53300055-B3AFC461-6B0E-4C8D-9433-C327FBEC176C

Q53300055-FD362A8F-3A7E-472F-B9AB-BD6F0F348D6D

P2860

Q53300055-09C796A1-D09E-466E-9B2A-61F6E64583BC

Q53300055-2DEDED3A-CBEE-46C6-9749-463DF4209773

Q53300055-40DDC1F1-B7C4-48AD-BBA3-9C7B33CA8809

Q53300055-53F8B7A7-D5A6-4D9F-9817-A9A42A2D2B5D

Q53300055-55332972-8801-4332-8611-630285DEAF77

Q53300055-556C2136-3163-45CD-9433-1FC30256BC56

Q53300055-7B5EEF7F-A354-48C0-B92E-7F523260854E

Q53300055-8E28F6B3-9209-48F4-B357-F52E3A8CEBAE

Q53300055-916B2280-CC4D-4961-918E-206AC6D86CCF

Q53300055-ABD2C516-0BD8-4A37-8350-C98B6F2E781D

P304

Q53300055-63DB8B21-4844-46F1-8F10-10AE0DBA972F

P31

Q53300055-1956F906-A2FD-4322-9642-CCD5F67220C4

P356

Q53300055-7CAE1F13-3802-4A02-BE87-506F44F47410

P433

Q53300055-6A56A51E-4AC5-41E0-B2BD-9D7E67B13F2E

P478

Q53300055-9CD27EBC-6B1D-48D3-9461-7755399A0770

P577

Q53300055-9B8441DD-C58E-4F28-8FE5-1C8FF40C8154

P698

Q53300055-C94C75E5-72B6-46C9-8F7B-E8885BCCA66C

P356

P1433

Journal of Neuropathology & Experimental Neurology

P1476

Morphophenotypic variation pre ...... desmoplastic medulloblastomas.

@en

P2093

Andrew D J Pearson

http://www.w3.org/2001/XMLSchema#string

Charles S McManamy

http://www.w3.org/2001/XMLSchema#string

David W Ellison

http://www.w3.org/2001/XMLSchema#string

Jayne M Lamont

http://www.w3.org/2001/XMLSchema#string

Michael Cole

http://www.w3.org/2001/XMLSchema#string

Roger E Taylor

http://www.w3.org/2001/XMLSchema#string

Steven C Clifford

http://www.w3.org/2001/XMLSchema#string

United Kingdom Children's Cancer Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Medulloblastoma with extensive nodularity: a variant with favorable prognosis.

Childhood medulloblastoma in Denmark 1960-1984. A population-based retrospective study.

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Medulloblastoma in children--the Ottawa experience.

Cell proliferation and tumors of the central nervous system, part II: radiolabeling, cytometric, and immunohistochemical techniques.

Classifying the medulloblastoma: insights from morphology and molecular genetics.

Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.

Mitotic percentage index: a new prognostic factor for childhood medulloblastoma.

P304

627-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/62.6.627

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12834107

http://www.w3.org/2001/XMLSchema#string